- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Postprandial Lipid Metabolism in Sweden
Total 1131 results
-
Lund UniversitySwedish Foundation for Strategic ResearchCompleted
-
Lund UniversitySwedish Foundation for Strategic ResearchCompleted
-
Lund UniversitySwedish Foundation for Strategic ResearchCompleted
-
Lund UniversityAnti-Diabetic Food CentreCompletedPostprandial Blood Glucose RegulationSweden
-
Karolinska InstitutetCompletedType 2 Diabetes Mellitus | Postprandial HyperglycemiaSweden
-
Uppsala UniversityCompleted
-
Karo Bio ABCompleted
-
Lund UniversityUniversity of CopenhagenCompletedPostprandial Glucose and Insulin ResponseSweden
-
Uppsala UniversityLund University; Arla Foods; Vinnova; The Swedish Research Council for Environment... and other collaboratorsCompletedHypercholesterolemiaSweden
-
Karo Bio ABCompleted
-
Region Örebro CountyRecruiting
-
DoubleGood ABLund UniversityCompletedType 2 Diabetes Mellitus | Metabolic Syndrome | Postprandial HyperglycemiaSweden
-
University Hospital, LinkoepingRecruitingHypercholesterolemia, Familial | Clinical Decision SupportSweden
-
Karolinska InstitutetEnrolling by invitationHypercholesterolemia | Familial HypercholesterolemiaSweden
-
Unilever R&DCompletedHealthy | Mildly Elevated Cholesterol LevelsSweden
-
Karo Bio ABCompleted
-
University Hospital, LinkoepingRecruiting
-
Karolinska InstitutetCompletedEndothelial Dysfunction | HypercholesteremiaSweden
-
Göteborg UniversityÖrebro University, SwedenCompletedBlood Glucose | Lipid Metabolism | Oral Glucose Tolerance Test | Carbohydrate MetabolismSweden
-
Genzyme, a Sanofi CompanyCompletedFamilial HypercholesterolemiaNetherlands, France, Germany, Sweden, United Kingdom
-
Umeå UniversityCounty Council of Norrbotten, SwedenCompletedHypertension | Obesity | Type 2 Diabetes | DyslipidemiaSweden
-
Karolinska InstitutetRecruitingCardiovascular Diseases | Dyslipidemias | Hereditary DiseasesSweden
-
Vastra Gotaland RegionKarolinska University Hospital; Göteborg University; Uppsala University HospitalCompleted
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Karolinska InstitutetCompletedDyslipidemia | Type 1 Diabetes MellitusSweden
-
Marja-Riitta TaskinenGöteborg UniversityEnrolling by invitationInsulin Resistance | Non-alcoholic Fatty Liver | Atherogenic DyslipidemiaFinland, Sweden
-
Marja-Riitta TaskinenLund University; Sahlgrenska University Hospital, Sweden; Laval University; University...CompletedHypertriglyceridemia | Central ObesityCanada, Finland, Italy, Sweden
-
SanofiTerminatedHypercholesterolemiaUnited States, France, Canada, Poland, Russian Federation, Germany, Netherlands, Spain, Sweden, Belgium, Czech Republic, Denmark, Hungary, Israel, Norway, Australia
-
Karolinska University HospitalEnrolling by invitationObesity | Dyslipidemia | Non-alcoholic Fatty Liver Disease | Diabetes Mellitus Type 2Sweden
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolaemiaNorway, Russian Federation, Sweden, South Africa, Czechia, United States, Canada, France, Netherlands, Spain
-
Ionis Pharmaceuticals, Inc.Active, not recruitingFamilial Chylomicronemia SyndromeUnited States, Canada, Sweden
-
SanofiTerminatedObesity | DyslipidemiasGermany, Netherlands, Turkey, Slovakia, United Kingdom, Finland, Hungary, Ireland, Italy, Norway, Greece, Sweden, Czech Republic, Portugal, Switzerland
-
AstraZenecaCompletedHypertriglyceridemia | Non-alcoholic Fatty Liver Disease (NAFLDSweden
-
SanofiCompletedObesity | DyslipidemiaUnited States, Canada, Brazil, Australia, Italy, Sweden, Malaysia, Singapore, Taiwan, Mexico, Denmark, Korea, Republic of, Hong Kong, South Africa
-
Kowa Research EuropeCompletedDyslipidemia | HypercholesterolemiaSpain, Sweden, Denmark, Netherlands
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Australia, Belgium, Spain, Finland, Sweden, Canada
-
ShireCompletedFabry DiseaseFinland, Sweden, Germany, Belgium, Czechia, Denmark
-
AmgenCompletedHyperlipidemiaCanada, France, Netherlands, United Kingdom, New Zealand, South Africa, Spain, United States, Australia, Germany, Sweden, Hong Kong, Switzerland, Norway
-
GlaxoSmithKlineCompletedDyslipidaemia | DyslipidaemiasGermany, Estonia, Belgium, France, Netherlands, Denmark, Portugal, Norway, Sweden, Lithuania, Finland
-
PfizerCompletedHyperlipidemia | Hypercholesterolemia, FamilialAustralia, Canada, United States, France, South Africa, Sweden, Norway, Denmark, Iceland
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolaemiaCzechia, France, Denmark, Netherlands, Austria, Mexico, Spain, United States, Argentina, Brazil, Bulgaria, Canada, Finland, Hungary, Italy, Lebanon, Norway, Poland, Russian Federation, Slovenia, South Africa, Sweden, Taiwan, Turkey
-
AmgenTerminatedPregnancy | HypercholesterolaemiaBelgium, Denmark, Italy, Czechia, United Kingdom, Australia, Austria, Greece, Switzerland, Netherlands, Spain, Sweden, Slovakia, Norway
-
Kowa Research EuropeCompletedDyslipidemia | HypercholesterolemiaSpain, Denmark, India, Israel, Sweden, Finland, Germany, Italy, Netherlands, Norway, Poland, Russian Federation, United Kingdom
-
The Medicines CompanyCompletedElevated Cholesterol | Heterozygous Familial HypercholesterolemiaUnited States, Canada, Czechia, Denmark, Netherlands, South Africa, Spain, Sweden
-
AmgenTerminatedDyslipidemiaBelgium, Denmark, Germany, Sweden, France, Italy, Portugal
-
Kowa Research EuropeCompletedDyslipidemia | Primary HypercholesterolemiaSpain, Denmark, India, Israel, Sweden, Finland, Germany, Italy, Netherlands, Norway, Poland, Russian Federation, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaUnited States, Austria, Canada, Czech Republic, Denmark, France, Israel, Netherlands, Norway, Russian Federation, South Africa, Spain, Sweden, United Kingdom
-
Ionis Pharmaceuticals, Inc.Active, not recruitingFamilial Chylomicronemia SyndromeSpain, United Kingdom, France, Canada, United States, Italy, Netherlands, Norway, Portugal, Slovakia, Sweden